These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2474777)

  • 21. Alzheimer's disease: monoamines and spiperone binding reduced in nucleus basalis.
    Sparks DL; Markesbery WR; Slevin JT
    Ann Neurol; 1986 Jun; 19(6):602-4. PubMed ID: 2425718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Change in levels of monoamine neurotransmitters and their main metabolites of rat brain after electric acupuncture treatment.
    Wenhe Z; Yucun S
    Int J Neurosci; 1981; 15(3):147-9. PubMed ID: 6171540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infusion of iron into the rat substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markers.
    Sengstock GJ; Olanow CW; Menzies RA; Dunn AJ; Arendash GW
    J Neurosci Res; 1993 May; 35(1):67-82. PubMed ID: 7685399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
    Sparks DL; Hunsaker JC; Slevin JT; DeKosky ST; Kryscio RJ; Markesbery WR
    Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional brain variations of tryptophan, monoamines, monoamine oxidase activity, plasma free and total tryptophan during the estrous cycle of the rat.
    Kueng W; Wirz-Justice A; Menzi R; Chappuis-Arndt E
    Neuroendocrinology; 1976; 21(4):289-96. PubMed ID: 1035790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple biochemical deficits in both gray and white matter of Alzheimer brains.
    Gottfries CG; Bartfai T; Carlsson A; Eckernäs S; Svennerholm L
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):405-13. PubMed ID: 3797685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous measurement of biogenic amines and related compounds by high performance liquid chromatography (HPLC).
    Shibuya T; Sato K; Salafsky B
    Int J Clin Pharmacol Ther Toxicol; 1982 Jul; 20(7):297-301. PubMed ID: 7107080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotransmitters in dementia.
    Nakamura S; Koshimura K; Kato T; Yamao S; Iijima S; Nagata H; Miyata S; Fujiyoshi K; Okamoto K; Suga H
    Clin Ther; 1984; 7 Spec No():18-34. PubMed ID: 6152197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concentrations of monoamines and their metabolites in the cerebrospinal fluid from patients with senile dementia of the Alzheimer type and vascular dementia of the Binswanger type.
    Tohgi H; Ueno M; Abe T; Takahashi S; Nozaki Y
    J Neural Transm Park Dis Dement Sect; 1992; 4(1):69-77. PubMed ID: 1540305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Piperidine: effects on locomotor activity and brain monoamine turnover.
    Alm B
    Psychopharmacology (Berl); 1976 Nov; 50(3):301-4. PubMed ID: 826977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mass fragmentographic analysis of monoamine metabolites in the spinal cord of rat after the administration of morphine.
    Commissiong JW
    J Neurochem; 1983 Nov; 41(5):1313-8. PubMed ID: 6194263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid (CSF) and brain monoamine metabolites in the developing rat pup.
    Shaywitz BA; Anderson GM; Cohen DJ
    Brain Res; 1985 Jan; 349(1-2):225-32. PubMed ID: 2580600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease.
    Vermeiren Y; Van Dam D; Aerts T; Engelborghs S; De Deyn PP
    Neurobiol Aging; 2014 Dec; 35(12):2691-2700. PubMed ID: 24997673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of brain monoamine precursors on stress-induced behavioral and neurochemical changes in aged mice.
    Thurmond JB; Brown JW
    Brain Res; 1984 Mar; 296(1):93-102. PubMed ID: 6201238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations of brain monoamine levels in pigs exposed to acute immobilization stress.
    Piekarzewska A; Sadowski B; Rosochacki SJ
    Zentralbl Veterinarmed A; 1999 May; 46(4):197-207. PubMed ID: 10399478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in biogenic amines in rat hippocampus during development and aging.
    Santiago M; Machado A; Reinoso-Suárez F; Cano J
    Life Sci; 1988; 42(24):2503-8. PubMed ID: 2453775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytomegalovirus infection of the developing brain alters catecholamine and indoleamine metabolism.
    O'Kusky JR; Boyes BE; Walker DG; McGeer EG
    Brain Res; 1991 Sep; 559(2):322-30. PubMed ID: 1724407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developmental variations of brain serotonin, tryptophan, 5-hydroxyindole acetic acid, and noradrenaline and dopamine content in two inbred strains of mice.
    Daszuta A; Barrit MC; Faudon M
    Dev Neurosci; 1982; 5(2-3):130-42. PubMed ID: 6181954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tissue concentrations of biogenic amines in brain tumors and their distribution].
    Ikeda Y; Nakazawa S
    No Shinkei Geka; 1984 Jun; 12(7):787-93. PubMed ID: 6483088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlative analysis of dopaminergic and serotonergic metabolism across the brain to study monoaminergic function and interaction.
    Dellu-Hagedorn F; Fitoussi A; De Deurwaerdère P
    J Neurosci Methods; 2017 Mar; 280():54-63. PubMed ID: 28161298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.